• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (COSTA RICA) ORBERA INTRAGASTRIC BALLOON; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (COSTA RICA) ORBERA INTRAGASTRIC BALLOON; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Catalog Number B-50000
Device Problem Migration or Expulsion of Device (1395)
Patient Problems Syncope (1610); Nausea (1970); Vomiting (2144)
Event Type  Injury  
Manufacturer Narrative
The reporter of the complaint was asked to return the product for analysis.The device has not yet been received by allergan.Allergan has not received the product at this time.Therefore no analysis or testing has been done.Vomiting, syncope, nausea, impaired lifestyle and malaise are surgical/physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events.No additional information has been reported to allergan regarding the serial number, the event date, implant date, treatment date, explant date, patient data or further event details.(b)(4).Device labeling addresses the reported event of device migration as follows: possible complications of the use of the orbera¿ system include: intestinal obstruction by the balloon.An insufficiently inflated balloon or a leaking balloon that has lost sufficient volume may be able to pass from the stomach into the small bowel.It may pass all the way through into the colon and be passed with stool.However, if there should be a narrow area in the bowel, as might occur after prior surgery on the bowel and adhesion formation, the balloon may not pass and then may cause a bowel obstruction.If this occurs, percutaneous drainage, surgery, or endoscopic removal could be required.Device labeling addresses the reported events of vomiting and nausea as follows: possible complications of the use of the orbera¿ system include: gastric discomfort, feelings of nausea and vomiting following balloon placement as the digestive system adjusts to the presence of the balloon.Device labeling addresses the contraindication for patients regarding impaired lifestyle as follows: possible complications of the use of the orbera¿ system include: influence on digestion of food.Blockage of food entering into the stomach.Device labeling addresses the reported event of syncope and malaise as follows: the physiological response of the patient to the presence of the orbera¿ system balloon may vary depending upon the patient¿s general condition and the level and type of activity.The types and frequency of administration of drugs or diet supplements and the overall diet of the patient may also affect the response.
 
Event Description
Patient reported vomiting, weakness, inability to stand or drink "a lot of water" and nausea.After starting solid diet, patient reported dizziness.Physician performed a second endoscopic procedure to "reposition the balloon" as it "moved of its initial place because of vomiting." device remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON
Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS 
Manufacturer (Section G)
ALLERGAN (COSTA RICA)
900 parkway global park
zona franca
CS  
Manufacturer Contact
laura leboeuf
1120 s capital of texas hwy
building 1, suite 300
austin, TX 78748
8555513123
MDR Report Key5178022
MDR Text Key29250166
Report Number3006722112-2015-00502
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Type of Report Initial
Report Date 10/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberB-50000
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/06/2015
Initial Date FDA Received10/26/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-